PCP
EVH icon

Proficio Capital Partners’s Evolent Health EVH Stock Holding History

Proficio Capital Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-168
Closed -$1K – 592
2019
Q2 		$1K Buy
+168
New +$1.99K ﹤0.01% 1722

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Proficio Capital Partners's EVH Position: Q3 2019 in Review

Proficio Capital Partners sold out of Evolent Health (EVH) in Q3 2019, closing a stake of 168 shares — an estimated $1K sold.

Proficio Capital Partners first reported a position in EVH in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 174 funds tracked by Wall St. Rank hold EVH as of Q3 2019.

  • Proficio Capital Partners reported no remaining Evolent Health position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 168 Evolent Health shares in Q3 2019, an estimated $1K.
  • Proficio Capital Partners first reported a position in Evolent Health in Q2 2019 and held it in 1 quarter.
  • Proficio Capital Partners's Evolent Health position peaked at $1K in Q2 2019.
  • 174 funds tracked by Wall St. Rank held Evolent Health as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.